NCT07087548

Brief Summary

The goal of this clinical trial is to compare the effectiveness of peloid therapy versus hot pack therapy in adults aged 18-50 with chronic lumbar disc herniation (LDH). The main questions it aims to answer are: Does peloid therapy reduce pain more effectively than hot pack therapy in patients with chronic LDH? Does peloid therapy improve functional status, range of motion, and quality of life more than hot pack therapy? Researchers will compare peloid therapy (45°C for 30 minutes, 5 days/week) to hot pack therapy (20 minutes, 5 days/week) to see which treatment offers better clinical outcomes. Participants will: Receive either peloid therapy or hot pack therapy for 3 weeks (15 sessions total). Undergo standard TENS therapy (20 minutes to the lumbar region) after each session. Complete assessments before and after treatment including: Pain intensity (Visual Analog Scale - VAS) Functional status (Back Pain Functional Scale - BPFS) Disability level (Oswestry Disability Index - ODI) Quality of life (Short Form-36 - SF-36) Lumbar range of motion and finger-to-floor distance (FFD)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2022

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

July 19, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 28, 2025

Completed
Last Updated

July 28, 2025

Status Verified

September 1, 2021

Enrollment Period

10 months

First QC Date

July 19, 2025

Last Update Submit

July 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain intensity (VAS)

    Pain severity was assessed with the Visual Analog Scale (VAS), which is scored between 0 and 10, and is used to evaluate pain. 0 denotes no pain and 10 denotes unbearably severe pain. Participants were instructed to indicate the level of pain they experienced by marking a point along a 10 cm straight line, and the value found was recorded in cm

    Before treatment and after treatment (3rd week).

Secondary Outcomes (5)

  • Impact of daily activities on a person's life (Oswestry Disability Index)

    before treatment and after treatment (3rd week)

  • Assessing functional loss due to low back pain (Back Pain Functional Scale )

    before treatment and after treatment (3rd week)

  • Quality of Life (SF-36)

    before treatment and after treatment (3rd week)

  • Active ROM measurements (flexion, extension, left and right lateral flexion, and rotation)

    before treatment and after treatment (3rd week)

  • Finger-floor distance measurement

    before treatment and after treatment (3rd week)

Study Arms (2)

Experimental (Peloid Therapy+TENS)

EXPERIMENTAL

The peloid therapy group received 15 sessions of peloid therapy at 45°C for 30 minutes per session, five days a week for three weeks. Peloid was applied to the lumbar region with a brush to a thickness of approximately 15 mm. The area was then wrapped with stretch film and a towel for 30 minutes to minimize heat loss. Peloids produced and packaged in the Afyonkarahisar Sandıklı geothermal region were used. The peloid is gray, odorless, and has a pH of 8.74. It contains humic acid, humin, lignin, hemicellulose, montmorillonite, calcite, and kaolinite. After the peloid application, the area was cleaned, and conventional TENS (80 Hz frequency) was applied to the waist for 20 minutes.

Other: Peloid Therapy

Hot pack Therapy (Hotpack+TENS)

ACTIVE COMPARATOR

The hot pack group applied 20 minutes, 5 days a week, once a day, for 15 sessions on the lumbar region. The boiler temperature of the hot packs used was 90 °C. Two towels were used, with the thickest side of the towels placed on the lumbar area of the individuals. Then, conventional TENS (80 Hz frequency) was applied to the painful area in the lumbar region for 20 minutes

Other: Hotpack Therapy

Interventions

Peloid therapy will be applied using medical mud packs at 45°C for 30 minutes per session, 5 sessions per week for 3 consecutive weeks. The therapy will be administered to the lower back region in patients diagnosed with chronic lumbar disc herniation. This intervention aims to reduce pain and improve function through thermomechanical and biochemical effects of natural peloid.

Experimental (Peloid Therapy+TENS)

The hot pack group applied 20 minutes, 5 days a week, once a day, for 15 sessions on the lumbar region. The boiler temperature of the hot packs used was 90 °C. Two towels were used, with the thickest side of the towels placed on the lumbar area of the individuals. Then, conventional TENS (80 Hz frequency) was applied to the painful area in the lumbar region for 20 minutes

Hot pack Therapy (Hotpack+TENS)

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals ≥18 years old with CLBP due to LDH lasting more than three months
  • Individuals who showed degeneration and prolapsed herniation on magnetic resonance imaging
  • Individuals were examined by a specialist physician

You may not qualify if:

  • having not received physiotherapy for LDH in the last 6 months,
  • severe neurological deficit,
  • osteoporosis,
  • malignancy, inflammatory disease
  • decompensated cardiopulmonary disease,
  • uncontrolled hypertension,
  • those with an important pathology in routine laboratory tests (liver and kidney dysfunction, individuals with thyroid dysfunction, diabetes),
  • vertebral fracture,
  • lumbar listhesis
  • infectious disease at lumbar level,
  • inflammatory lumbar pain,
  • individuals with extruded and sequestered herniation as a result of MRI,
  • those with neurological deficits,
  • communication problems,
  • being allergic to peloid or hotpack
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sancak Tıp Merkezi

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Mud Therapy

Intervention Hierarchy (Ancestors)

BalneologyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

July 19, 2025

First Posted

July 28, 2025

Study Start

September 1, 2021

Primary Completion

June 22, 2022

Study Completion

June 22, 2022

Last Updated

July 28, 2025

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations